BackTransnational Cannabis Overview

Transnational Cannabis EBIT

Transnational Cannabis's EBIT is $-110M, below the sector sector average of $2.3T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.82M
↓ 2.11% YoY

As of Nov 30, 2019

Annual EBIT (TTM)

-$109.62M
↓ 49.75% YoY

Trailing 12 months ending Nov 30, 2019

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Transnational Cannabis (TRCNF) FAQ

Transnational Cannabis posts a EBIT of $-110M as of November 2019. That compares with $-73M in the prior-year period — down 49.8% year over year. That is below the sector sector average of $2.3T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Transnational Cannabis's EBIT was $-73M. The latest reading is $-110M — a 49.8% year-over-year decrease (period ending November 2019). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a EBIT near $2.3T is typical. Transnational Cannabis's $-110M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Transnational Cannabis's financial statement story. At $-110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TRCNF's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $2.3T), and (3) consistency with growth and profitability. This page covers the first two; Transnational Cannabis's other metric pages and overview cover the third.

Questions & Answers